Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centrica PLC Share Issue/Capital Change 2019

Nov 15, 2019

5292_rns_2019-11-15_25bd59fd-f3c6-49cf-b437-732a4bd835ab.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5798T

Centrica PLC

15 November 2019

15 November 2019

Centrica plc

(the "Company")

Blocklisting Application

Application has been made to the Financial Conduct Authority and the London Stock Exchange Plc for a total of 14,000,000 ordinary shares of 6 14/81 pence each ("shares") to be admitted to the Official List. It is expected that admission will be granted on 18 November 2019.

These shares are being reserved under block listings and will be issued in connection with awards of shares under the Centrica Share Incentive Plan (2,000,000 shares), Centrica North American Employee Share Purchase Plan (800,000 shares), Centrica On Track Incentive Plan (incorporating the Centrica Conditional Share Incentive Plan) (10,000,000 shares), and Centrica Long Term Incentive Plan (1,200,000 shares).

When issued, these shares will rank pari passu with the existing ordinary shares.

Alan McCulloch

Head of Group Secretariat, Centrica plc

01753 494000

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSDMMMMLKLGLZG